SCHEMBL7928941

SCHEMBL7928941

COc1cccc(-c2ccc3ccccc3c2Oc2ccc(NC(=O)CCl)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RNF4 P78317 1/20 0.51
MTNR1B P49286 7/20 0.49
MTNR1A P48039 5/20 0.49
PLAU P00749 2/20 0.47
ALDH1A1 P00352 2/20 0.46
HTT P42858 2/20 0.46
POLB P06746 2/20 0.46
MITF O75030 1/20 0.46
MAPK1 P28482 1/20 0.46
PLG P00747 1/20 0.45
PLAT P00750 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
DGAT2 Q96PD7 1/20 0.43
GMPS P49915 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7938155 0.93 MTNR1B (0.50) RNF4MTNR1BMTNR1APLAUALDH1A1
SCHEMBL7935140 0.92 MTNR1B (0.55) MTNR1BMTNR1APLAUPLGPLAT
SCHEMBL7935128 0.90 MTNR1B (0.49) MTNR1BMTNR1APLAUPOLBPLG
SCHEMBL7935093 0.89 MTNR1B (0.53) MTNR1BMTNR1APLAUALDH1A1PLG
SCHEMBL7928830 0.84 PLAU (0.47) RNF4MTNR1BMTNR1APLAUPLG
SCHEMBL7940509 0.83 MTNR1B (0.50) MTNR1BMTNR1APLAUPLGPLAT
SCHEMBL6050235 0.80 MIF (0.46) MEN1KMT2A
SCHEMBL8500385 0.80 TDP1 (0.47) MTNR1BMTNR1ADGAT2
SCHEMBL7937751 0.80 KMT2A (0.47) MTNR1BMTNR1AALDH1A1HTTPOLB
SCHEMBL7937755 0.79 FGFR1 (0.44) RNF4MTNR1BMTNR1APLAUPLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0835868-B1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods LILLY CO ELI (US) 2001-08-29 EP disclosed
US-5929090-A NOVEL COMPOUNDS FOR TREATING ESTROGEN DEPRIVATION CAUSED BY MENOPAUSE OR OVARIECTOMY; TREATING OSTEOPOROSIS, CARDIOVASCULAR DISEASES, AND ENDOMETRIOSIS ELI LILLY AND COMPANY (US) 1999-07-27 US disclosed
EP-0835868-A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods ELI LILLY AND COMPANY (US) 1998-04-15 EP disclosed